Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 1;5(1):1030.
Epub 2021 Nov 30.

Comparison of the clinical efficacy of penicillin and ceftriaxone sodium in the treatment of neurosyphilis with psychiatric symptoms

Affiliations

Comparison of the clinical efficacy of penicillin and ceftriaxone sodium in the treatment of neurosyphilis with psychiatric symptoms

Shibin Wang et al. World J Psychiatry Ment Health Res. .

Abstract

Objective: To compare the clinical efficacy of penicillin and ceftriaxone sodium in the treatment of neurosyphilis with psychiatric symptoms.

Methods: 50 neurosyphilis with mental symptoms patients were randomly divided into penicillin group (4 million units, Q4h) and ceftriaxone sodium group (1 g, Q12h). The total treatment time was 14 and 15 days respectively.The activity of daily living scale (ADL), brief psychiatric rating scale (BPRS) and mini-mental state examination (MMSE) were scored as the measurement of efficiency in living ability, mental symptoms and cognitive function.

Result: There were no significant differences in ADL, MMSE and BPRS between the penicillin group and the ceftriaxone sodium treatment group (p > 0.05). After treatment, the score of BPRS and ADL decreased from baseline, while MMSE scores increased from baseline, having a main time effect (F=31.098,F=26.342,F= 79.916; p < 0.05).

Conclusion: Penicillin or ceftriaxone sodium are both effective in the aspect of mental symptoms, cognitive function and life ability among neurosyphilis with psychiatric symptoms patients.

Keywords: ceftriaxone sodium; clinical efficacy; neurosyphilis; penicillin; psychiatric symptoms.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None.

Similar articles

Cited by

References

    1. The L. Syphilis: an ancient disease in a modern era. Lancet. 2017;389(10078):1492. - PubMed
    1. Costiniuk CT, MacPherson PA. Neurocognitive and psychiatric changes as the initial presentation of neurosyphilis. CMAJ. 2013;185(6):499–503. - PMC - PubMed
    1. Wang J, Guo Q, Zhou P, Zhang J, Zhao Q, Hong Z. Cognitive impairment in mild general paresis of the insane: AD-like pattern. Dementia and geriatric cognitive disorders. 2011;31(4):284–90. - PubMed
    1. Stefani A, Riello M, Rossini F, Mariotto S, Fenzi F, Gambina G, et al. Neurosyphilis manifesting with rapidly progressive dementia: report of three cases. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2013;34(11):2027–30. - PubMed
    1. Roberts MC, Emsley RA. Cognitive change after treatment for neurosyphilis. Correlation with CSF laboratory measures. General hospital psychiatry. 1995;17(4):305–9. - PubMed

LinkOut - more resources